BertKLopansriMD
Infectious Disease • Salt Lake City, UTAssociate Professor, Internal Medicine, University of Utah School of Medicine
Dr. Lopansri is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
400 C St
Salt Lake City, UT 84143Phone+1 801-408-2293Fax+1 801-507-7780
Education & Training
University of Utah HealthFellowship, Infectious Disease, 2000 - 2003
Loyola University Medical CenterResidency, Internal Medicine, 1997 - 2000
Loyola University Chicago Stritch School of MedicineClass of 1997
Certifications & Licensure
UT State Medical License 2000 - 2026
ID State Medical License 2016 - 2025
MT State Medical License 2019 - 2025
WY State Medical License 2019 - 2025
IL State Medical License 1997 - 2014
MO State Medical License 2009 - 2012- American Board of Internal Medicine Infectious Disease
Clinical Trials
- VENUS: Septic Gene Expression Using SeptiCyte Start of enrollment: 2014 Apr 01
Publications & Presentations
PubMed
- 103 citationsIdentification of Gram-Negative Bacteria and Genetic Resistance Determinants From Positive Blood Culture Broths by Use of the Verigene Gram-Negative Blood Culture Mult...Nathan A. Ledeboer, Bert K. Lopansri, Neelam Dhiman, Robert Cavagnolo, Karen C. Carroll
Journal of Clinical Microbiology. 2015-08-01 - 3 citationsThe Influence of Social Determinants on Receiving Outpatient Treatment with Monoclonal Antibodies, Disease Risk, and Effectiveness for COVID-19.Nalini Ambrose, Alpesh Amin, Brian Anderson, Monica Bertagnolli, Francis Campion
Journal of General Internal Medicine. 2023-12-01 - 44 citationsAntibiotic Exposure and Risk for Hospital-Associated Clostridioides difficile InfectionBrandon J. Webb, Aruna Subramanian, Bert K. Lopansri, Bruce E. Goodman, Peter Bjorn Jones
Antimicrobial Agents and Chemotherapy. 2020-03-24
Press Mentions
Utah Hospital Hits Record Number of COVID Tests Since Pandemic BeganMarch 21st, 2022- SEC Investigators Made Inquiries About COVID-19 Tests Sold by Utah Company, the Salt Lake Tribune Has LearnedJune 17th, 2021
- Intermountain Healthcare Hits 1 Million COVID-19 Tests; Utah Adds 1,201 New Cases, 17 DeathsFebruary 2nd, 2021
- Join now to see all
Grant Support
- Severe Falciparum Malaria: Mechanisms Of HypoargininemiaNational Institute Of Allergy And Infectious Diseases2003–2006
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
